Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

Michael D. De Bellis, Philip W. Gold, Thomas D. Geracioti, Samuel J. Listwak, Mitchel A. Kling

Research output: Contribution to journalArticlepeer-review

283 Scopus citations

Abstract

The authors measured CSF concentrations of corticotropin-releasing hormone (CRH) and arginine vasopressin in nine depressed patients before and after fluoxetine treatment. They found significant decreases in CSF CRH, CSF arginine vasopressin, and Hamilton depression ratings. Thus, the therapeutic effect of this serotonin-uptake inhibitor may be related to diminution of these arousal-promoting neuropeptides.

Original languageEnglish (US)
Pages (from-to)656-657
Number of pages2
JournalAmerican Journal of Psychiatry
Volume150
Issue number4
DOIs
StatePublished - 1993
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression'. Together they form a unique fingerprint.

Cite this